Incretin-based drugs and risk of lung cancer among individuals with type 2 diabetes.
J RouetteH YinO H Y YuN BouganimR W PlattLaurent AzoulayPublished in: Diabetic medicine : a journal of the British Diabetic Association (2020)
In individuals with type 2 diabetes, use of incretin-based drugs was not associated with increased lung cancer risk.
Keyphrases